Showing results (21-30 of 1,069) with videos related to
Sort By:
Pageof 107
Therapeutic Advances in Neurological Disorders|February 6, 2018
Vascular medicine and thrombectomy in strokeSebastian Fischer, Werner WeberTherapeutic Advances in Neurological Disorders|February 6, 2018
An epidemiological study on the course of disease and therapeutic considerations in relapsing-remitting multiple sclerosis patients receiving injectable first-line disease-modifying therapies in Germany (EPIDEM)Stephan Schmidt, Jürgen Koehler, Christine Winterstein, et al.Therapeutic Advances in Neurological Disorders|February 6, 2018
Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing-remitting multiple sclerosis: the CLARITY Extension studyGiancarlo Comi, Stuart Cook, Kottil Rammohan, et al.Therapeutic Advances in Neurological Disorders|February 7, 2018
Advances in the diagnosis, immunopathogenesis and therapies of IgM-anti-MAG antibody-mediated neuropathiesMarinos C DalakasTherapeutic Advances in Neurological Disorders|March 20, 2018
Mechanical thrombectomy in a young stroke patient with Duchenne muscular dystrophyCharlotte Spicher, Ruth Schneider, Peter Mönnings, et al.Therapeutic Advances in Neurological Disorders|March 30, 2018
B cell-based therapies in CNS autoimmunity: differentiating CD19 and CD20 as therapeutic targetsThomas G Forsthuber, Daniel M Cimbora, John Nolan Ratchford, et al.Therapeutic Advances in Neurological Disorders|March 8, 2018
Management of multiple sclerosis patients in central European countries: current needs and potential solutionsThomas Berger, Monika Adamczyk-Sowa, Tünde Csépány, et al.Therapeutic Advances in Neurological Disorders|May 5, 2021
High rates of JCV seroconversion in a large international cohort of natalizumab-treated patientsChristopher M Dwyer, Vilija G Jokubaitis, Jim Stankovich, et al.Therapeutic Advances in Neurological Disorders|May 5, 2021
Switch from intravenous to subcutaneous immunoglobulin IgPro20 in CIDP patients: a prospective observational study under real-world conditionsStefan Gingele, Moritz Koch, Anna Christina Saparilla, et al.Therapeutic Advances in Neurological Disorders|June 12, 2020
The role of erenumab in the treatment of migraineAnna P Andreou, Matteo Fuccaro, Giorgio LambruPageof 107